Skip to Content for (none) Menu for (none) About Us Menu Research Menu Development Menu Medicines Menu Investors Menu Media Menu Careers Menu
Banner Image
February Wednesday, Feb 24, 2010
Genentech Announces Positive Results of Avastin Phase III Study in Women with Advanced Ovarian Cancer

Monday, Feb 22, 2010
Phase III Study of Avastin Plus Chemotherapy in Advanced Stomach Cancer Did Not Meet Primary Endpoint

Thursday, Feb 18, 2010
FDA Approves Rituxan Plus Chemotherapy for the Most Common Type of Adult Leukemia

January Friday, Jan 15, 2010
FDA Extends Review Period for Tarceva Application for First-line Maintenance Use in Advanced Non-small Cell Lung Cancer

Friday, Jan 08, 2010
FDA Approves ACTEMRA® (tocilizumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis

December Wednesday, Dec 16, 2009
FDA Advisory Committee Recommends Against Approving Tarceva for First-Line Maintenance Use in Advanced Non-Small Cell Lung Cancer

Saturday, Dec 12, 2009
New Phase II Study Showed Trastuzumab-DM1 Shrank Tumors in Women With Highly Advanced HER2-positive Breast Cancer

Friday, Dec 11, 2009
Avastin Plus Commonly Used Chemotherapies Improved Progression-Free Survival in Women Previously Treated with Chemotherapy for Advanced Breast Cancer

See the Archives See the Archives
 
Search Releases

Begin Date:


End Date:


Category:
Keyword: